Vimarsana
Biggest News Aggregation in the World

Finish Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Finish Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Finish Services Today - Breaking & Trending Today

AstraZeneca to deliver Covid-19 antibody therapy doses to Switzerland - Vimarsana News

AstraZeneca to deliver Covid-19 antibody therapy doses to Switzerland

AstraZeneca has signed a deal with the Switzerland FOPH to deliver over 1,200 doses of tixagevimab and cilgavimab combination for Covid-19.

Bear market hits Europe's innovator drug venture financing, losing pace with US - Vimarsana News

Bear market hits Europe's innovator drug venture financing, losing pace with US

Biotech venture financing for innovator drugs in the US reached a total of $72bn from 2017 to 2022, while only $16bn was raised in Europe.

Covid-19 update: Global Covid deaths pass 6 million - Vimarsana News

Covid-19 update: Global Covid deaths pass 6 million

The global Covid death toll has passed the grim milestone of 6 million, with a figure of 6,007,367 according to Johns Hopkins University.

Worldwide Sterile Small Molecule Fill/Finish Services Industry to 2030 - Featuring Pfizer CentreOne, Delpharm & Rompharm Among Others - Vimarsana News

Worldwide Sterile Small Molecule Fill/Finish Services Industry to 2030 - Featuring Pfizer CentreOne, Delpharm & Rompharm Among Others

Share this article Share this article ResearchAndMarkets.com's offering. This report features an extensive study of the current market landscape and the future potential of sterile fill/finish services for small molecule drugs. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Small molecule drugs account for nearly 90% of the contemporary therapeutics pipeline. In fact, in 2019, the FDA's Center for Drug Evaluation and Research approved 48 small molecule drugs, representing 70% of the new molecular entities (NMEs) clearing regulat...